RUBY

15-12G - Rubius Therapeutics, Inc. (0001709401) (Filer)

SC 13G/A - Rubius Therapeutics, Inc. (0001709401) (Subject)

8-K - Rubius Therapeutics, Inc. (0001709401) (Filer)

25 - Rubius Therapeutics, Inc. (0001709401) (Filer)

DEF 14A - Rubius Therapeutics, Inc. (0001709401) (Filer)

  On Monday, 36 companies set new 52-week lows. Noteworthy Mentions In Today's 52-Week Lows: The largest company by market cap to hit a new 52-week low was Sirius XM Holdings (NASDAQ:SIRI). The smallest company by market cap to set a new 52-week low was Altamira Therapeutics (NASDAQ:CYTO). China Pharma Holding (AMEX:CPHI) saw the most significant move of the companies, as shares traded down 871.52% to reach its new 52-week low. VEON (NASDAQ:VEON) shares rebounded the highest, with shares trading up 0.0%, bouncing back after reaching its new 52-week low. Stocks dropping to new 52-week lows on Monday: Sirius XM Holdings (NASDAQ:SIRI) shares fell to $4.20 on Monday, setting a new 5

Gainers Unicycive Therapeutics, Inc. (NASDAQ:UNCY) shares surged 159% to $1.27 after the company announced a private placement of up to $130 million in gross proceeds to commercialize and launch Renazorb. BridgeBio Pharma, Inc. (NASDAQ:BBIO) shares jumped 59.5% to $17.34 after the company announced positive data for its phase 2 study of Infigratinib in Achondroplasia. Avalon GloboCare Corp. (NASDAQ:ALBT) shares gained 53.5% to $3.3330. Azul S.A. (NYSE:AZUL) gained 45.3% to $6.05 after the company announced a deal to reduce the immediate cash it must expend for leased property. Kala Pharmaceuticals, Inc. (NASDAQ:KALA) rose 28.3% to $21.49. HC Wainwright & Co. maintained Kala Pharmac

Gainers Unicycive Therapeutics (NASDAQ:UNCY) stock moved upwards by 151.2% to $1.23 during Monday's regular session. Trading volume for this security as of 12:30 EST is 77.1 million, which is 22303.6% of its average full-day volume over the last 100 days. The company's market cap stands at $18.5 million. Bellerophon Therapeutics (NASDAQ:BLPH) stock increased by 82.49% to $3.3. Bellerophon Therapeutics's stock is trading at a volume of 11.1 million shares as of 12:30 EST. This is 1023.2% of its average full-day volume over the last 100 days. The company's market cap stands at $31.4 million. BridgeBio Pharma (NASDAQ:BBIO) stock rose 58.0% to $17.18. Trading volume for BridgeBio Pharma's sto

Gainers Unicycive Therapeutics (NASDAQ:UNCY) shares increased by 114.3% to $1.05 during Monday's pre-market session. The company's market cap stands at $15.8 million. BridgeBio Pharma (NASDAQ:BBIO) stock moved upwards by 56.39% to $17.0. The market value of their outstanding shares is at $2.5 billion. vTv Therapeutics (NASDAQ:VTVT) stock increased by 48.51% to $1.2. The company's market cap stands at $97.7 million. Kala Pharmaceuticals (NASDAQ:KALA) shares increased by 27.46% to $21.35. The company's market cap stands at $39.9 million. The company's, Q4 earnings came out yesterday. TCR2 Therapeutics (NASDAQ:TCRR) shares rose 25.61% to $1.52. The market value of their outstanding shares

Gainers Secoo Holding Limited (NASDAQ:SECO) rose 44% to $1.44 in pre-market trading after dipping over 31% on Friday. Entera Bio Ltd. (NASDAQ:ENTX) rose 43.1% to $1.46 in pre-market trading after dropping 5% on Friday. Entera Bio recently announced the FDA's acceptance of a Type D meeting review to affirm design of the pivotal, Phase 3 protocol for EB613 PTH mini tablets, as the first oral osteoanabolic treatment of post-menopausal osteoporosis. BuzzFeed, Inc. (NASDAQ:BZFD) rose 20.7% to $1.87 in pre-market trading. BuzzFeed is expected to release its Q4 financial results on Monday, March 13, 2023, after the closing bell. BYND Cannasoft Enterprises Inc. (NASDAQ:BCAN) rose 12.5% to $2.8

Gainers ObsEva SA (NASDAQ:OBSV) surged 86.6% to $0.1978 after dropping over 12% on Thursday. ObsEva recently announced strategic reorganization to consolidate operations in Switzerland. Altamira Therapeutics Ltd. (NASDAQ:CYTO) shares jumped 52.7% to $3.59 after the company said data from a recent peer-reviewed clinical study demonstrated Bentrio's superior nasal residence time and rheological properties. Lavoro Limited (NASDAQ:LVRO) gained 44.7% to $13.86. Lavoro and TPB Acquisition Corporation I announced completion of business combination. HUB Cyber Security (Israel) Ltd. (NASDAQ:HUBC) rose 36.6% to $1.71 after dipping 21% on Thursday. Seer, Inc. (NASDAQ:SEER) gained 35% to $5.68 a

SC 13G/A - Rubius Therapeutics, Inc. (0001709401) (Subject)

Gainers ObsEva SA (NASDAQ:OBSV) rose 93.1% to $0.2047 in pre-market trading after dropping over 12% on Thursday. ObsEva recently announced strategic reorganization to consolidate operations in Switzerland. Bullfrog AI Holdings, Inc. (NASDAQ:BFRG) rose 53.1% to $4.18 in pre-market trading. Bullfrog AI recently priced its IPO at $6.50 per share. Rubius Therapeutics, Inc. (NASDAQ:RUBY) rose 28.7% to $0.1461 in pre-market trading. Rubius Therapeutics recently outlined dissolution plan, after unsuccessful attempt on alternatives. Smart for Life, Inc. (NASDAQ:SMFL) rose 19.7% to $0.2278 in pre-market trading. Smart for Life is scheduled to hold shareholder meeting on March 15, 2023. HUB Cyb

Gainers Bullfrog AI Hldgs (NASDAQ:BFRG) stock increased by 47.6% to $4.03 during Friday's pre-market session. The company's market cap stands at $22.7 million. Rubius Therapeutics (NASDAQ:RUBY) shares moved upwards by 31.71% to $0.15. The company's market cap stands at $13.5 million. Ardelyx (NASDAQ:ARDX) shares rose 17.3% to $3.39. The market value of their outstanding shares is at $673.1 million. The company's, Q4 earnings came out yesterday. Akari Therapeutics (NASDAQ:AKTX) shares rose 16.24% to $0.38. The market value of their outstanding shares is at $28.2 million. Milestone Scientific (AMEX:MLSS) shares rose 13.92% to $0.9. The company's market cap stands at $62.8 million. Confor

PRER14A - Rubius Therapeutics, Inc. (0001709401) (Filer)

Gainers Reata Pharmaceuticals (NASDAQ:RETA) stock moved upwards by 178.0% to $86.65 during Wednesday's regular session. The current volume of 10.1 million shares is 1012.6% of Reata Pharmaceuticals's average full-day volume over the last 100 days (last updated at 12:30 EST). The market value of their outstanding shares is at $3.1 billion. OncoSec Medical (NASDAQ:ONCS) stock moved upwards by 92.59% to $2.08. Trading volume for this security as of 12:30 EST is 58.4 million, which is 7655.3% of its average full-day volume over the last 100 days. The company's market cap stands at $6.1 million. BiomX (AMEX:PHGE) stock increased by 48.84% to $0.6. Trading volume for BiomX's stock is 1.7 millio

4 - Rubius Therapeutics, Inc. (0001709401) (Issuer)

Gainers Lucira Health, Inc. (NASDAQ:LHDX) jumped 354% to $0.6369 after the company announced FDA authorization for its at-home combination COVID-19 & flu test. ContraFect Corporation (NASDAQ:CFRX) shares jumped 66% to $5.14. ObsEva SA (NASDAQ:OBSV) jumped 56.5% to $0.1299. ObsEva shares dropped over 50% on Friday after the company announced strategic reorganization to consolidate operations in Switzerland. Blackboxstocks Inc. (NASDAQ:BLBX) rose 33% to $0.7300. Blackboxstocks said it sees Q4 revenue of $950K-$1.05M. Moolec Science SA (NASDAQ:MLEC) gained 25.3% to $5.14. AERWINS Technologies Inc. (NASDAQ:AWIN) shares rose 24.5% to $2.0909 after gaining more than 10% on Friday. Fisker

PRE 14A - Rubius Therapeutics, Inc. (0001709401) (Filer)

Gainers Lucira Health (NASDAQ:LHDX) shares moved upwards by 217.8% to $0.44 during Monday's pre-market session. The company's market cap stands at $18.0 million. UpHealth (NYSE:UPH) shares moved upwards by 36.73% to $2.68. The company's market cap stands at $40.3 million. ContraFect (NASDAQ:CFRX) shares moved upwards by 32.9% to $4.12. The company's market cap stands at $2.2 million. Virax Biolabs Group (NASDAQ:VRAX) shares increased by 24.61% to $0.8. The company's market cap stands at $10.2 million. Sangamo Therapeutics (NASDAQ:SGMO) stock increased by 19.01% to $3.16. The market value of their outstanding shares is at $532.3 million. As per the news, the Q4 earnings report came out 3

10-K - Rubius Therapeutics, Inc. (0001709401) (Filer)

S-8 POS - Rubius Therapeutics, Inc. (0001709401) (Filer)

S-8 POS - Rubius Therapeutics, Inc. (0001709401) (Filer)

S-8 POS - Rubius Therapeutics, Inc. (0001709401) (Filer)

S-8 POS - Rubius Therapeutics, Inc. (0001709401) (Filer)